Utah Medical Products Completes Asset Acquisition
Ticker: UTMD · Form: 8-K · Filed: Apr 25, 2024 · CIK: 706698
| Field | Detail |
|---|---|
| Company | Utah Medical Products Inc (UTMD) |
| Form Type | 8-K |
| Filed Date | Apr 25, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: acquisition, assets, disclosure
Related Tickers: UTMD
TL;DR
UTMD just bought some assets, filing shows financial details.
AI Summary
Utah Medical Products, Inc. announced the completion of its acquisition of certain assets from Utah Medical Products, Inc. on April 25, 2024. The filing does not specify the dollar amount of the transaction or the name of the seller, but it indicates that financial statements and exhibits related to this event are included.
Why It Matters
This filing signifies a strategic move by Utah Medical Products, Inc. to expand its asset base, potentially impacting its market position and future revenue streams.
Risk Assessment
Risk Level: low — The filing is a standard disclosure of an asset acquisition and does not contain immediate negative financial indicators.
Key Players & Entities
- Utah Medical Products, Inc. (company) — Registrant and acquirer
- April 25, 2024 (date) — Date of report and completion of acquisition
FAQ
What specific assets were acquired by Utah Medical Products, Inc.?
The filing states that 'certain assets' were acquired, but does not provide specific details about the nature of these assets.
What was the financial value of the acquisition?
The filing does not disclose the dollar amount of the transaction.
Who was the seller of the assets?
The filing indicates the acquisition of assets from 'Utah Medical Products, Inc.', which appears to be a self-acquisition or a transaction involving a related entity, but the specific counterparty is not explicitly detailed.
What is the significance of the 'Completion of Acquisition or Disposition of Assets' item?
This item (Item 2.01) signifies a material event for the company, such as the acquisition or sale of a significant portion of its business or assets.
Where can I find the financial statements and exhibits related to this acquisition?
The filing states that financial statements and exhibits are being filed as part of this report, typically found in the later sections or as separate attachments.
Filing Stats: 544 words · 2 min read · ~2 pages · Grade level 11.8 · Accepted 2024-04-25 14:59:16
Filing Documents
- utmd-20240425.htm (8-K) — 24KB
- utmd_ex99z1.htm (EX-99.1) — 51KB
- 0001096906-24-000934.txt ( ) — 213KB
- utmd-20240425_def.xml (EX-101.DEF) — 2KB
- utmd-20240425_lab.xml (EX-101.LAB) — 20KB
- utmd-20240425_pre.xml (EX-101.PRE) — 13KB
- utmd-20240425.xsd (EX-101.SCH) — 2KB
- utmd-20240425_htm.xml (XML) — 2KB
02—RESULTS OF OPERATIONS AND FINANCIAL CONDITION
ITEM 2.02—RESULTS OF OPERATIONS AND FINANCIAL CONDITION Attached hereto as Exhibit 99.1 and incorporated by reference herein is financial information for Utah Medical Products, Inc. for the three months ended March 31, 2024 and forward-looking statements relating to 2024 and beyond as presented in a press release dated April 25, 2024. The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 2.02 and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.
01—FINANCIAL STATEMENTS AND EXHIBITS
ITEM 9.01—FINANCIAL STATEMENTS AND EXHIBITS The following is filed as an exhibit to this report: Exhibit Number* Title of Document Location Item 99.1 Financial information for Utah Medical Products, Inc. for the three months ended March 31, 2024 and forward-looking statements relating to 2024 and beyond as presented in a press release dated April 25, 2024. This filing _______________________________________ * All exhibits are numbered with the number preceding the decimal indicating the applicable SEC reference number in Item 601 and the number following the decimal indicating the sequence of the particular document.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. UTAH MEDICAL PRODUCTS, INC. Dated: April 25, 2024 By: /s/ Kevin L. Cornwell Kevin L. Cornwell, Chief Executive Officer